Quivive Pharma is a leading pharmaceutical brand that specializes in tackling the opioid crisis and improving patient safety. With a focus on innovation and research, Quivive Pharma offers a range of products and services aimed at addressing the dangers associated with opioids. The opioid crisis has claimed many lives, with respiratory depression being the leading cause of death in cases of overdose.

Quivive Pharma's solution lies in functional antagonism. By targeting the same receptor responsible for both analgesia and respiratory depression, their FDA-approved drug, Doxapram, reduces undesired side effects without compromising pain relief. In addition to preventing respiratory depression, Doxapram also counteracts other harmful opioid side effects, such as constipation.

Quivive Pharma's patented abuse deterrence technology adds an extra layer of safety by closing the primary gateway to opioid addiction. With a strong commitment to improving patient outcomes and combating the opioid crisis, Quivive Pharma is at the forefront of developing effective solutions. Explore their executive summary and company slide deck for more information.

To learn more about Quivive Pharma and their groundbreaking approach, reach out to them via the provided contact details